Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: rationale and design

BACKGROUND: Ischemic stroke and other vascular outcomes occur in 10–20% of patients in the 3 months following a TIA or minor ischemic stroke, and many are disabling. The highest risk period for these outcomes is the early hours and days immediately following the ischemic event. Aspirin is the most c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Stroke
Main Authors: Johnston, S. Claiborne, Easton, J. Donald, Farrant, Mary, Barsan, William, Battenhouse, Holly, Conwit, Robin, Dillon, Catherine, Elm, Jordan, Lindblad, Anne, Morgenstern, Lewis, Poisson, Sharon N., Palesch, Yuko
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412261/
https://ncbi.nlm.nih.gov/pubmed/23879752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijs.12129
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker